Cancer Family
Hematopoietic and Lymphoid Cell Neoplasm
CI-CAN-00000023Explore in graph →
HematologicNon-malignant4,231 active trials98 approved drugs1,009 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000023Explore in graph →
Clinical trials
18,680 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03806192 | Feasibility of Partners in Care Program for Caregivers of Patients With Acute Myeloid Leukemia | terminated | N/A | 12 | University of WashingtonOTHER | 1 | Jun 23, 2021 | clinicaltrials |
| NCT00988013 | Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies(IM-TMI) | completed | N/A | 14 | University of Illinois at ChicagoOTHER | 1 | Jun 14, 2021 |
| NCT01768845 | Unrelated Umbilical Cord Blood (UBC)Transplantation | completed | N/A | 34 | West Virginia UniversityOTHER | 1 | Jun 14, 2021 | clinicaltrials |
| NCT04920500 | Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients | unknown | N/A | 16 | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.INDUSTRY | 1 | Jun 9, 2021 | clinicaltrials |
| NCT04432818 | Digital Life Coaching for Myeloma Patients Undergoing Transplantation | completed | N/A | 17 | University of California, San FranciscoOTHER | 1 | Jun 4, 2021 | clinicaltrials |
| NCT04914143 | the Effect of Broken Ganoderma Lucidum Spore Powder on Quality of Life and Immune Function in Patients With Diffuse Large B-cell Lymphoma After Chemotherapy | unknown | N/A | 120 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 4, 2021 | clinicaltrials |
| NCT04904211 | Feasiblity and Safety of Home-based Intensive Chemotherapy | completed | N/A | 104 | Rigshospitalet, DenmarkOTHER | 1 | May 27, 2021 | clinicaltrials |
| NCT02530619 | Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia | unknown | N/A | 26 | Northwestern UniversityOTHER | 1 | May 26, 2021 | clinicaltrials |
| NCT04892160 | Distracting Through Procedural Pain and Distress | completed | N/A | 67 | Medical College of WisconsinOTHER | 1 | May 19, 2021 | clinicaltrials |
| NCT01004718 | Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT) | completed | N/A | 10 | Abramson Cancer Center at Penn MedicineOTHER | 1 | May 18, 2021 | clinicaltrials |
| NCT02037256 | Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma | completed | N/A | 23 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | May 10, 2021 | clinicaltrials |
| NCT03083327 | Prophylactic Early PN in HPT/BMT | unknown | N/A | 408 | University of SydneyOTHER | 2 | Apr 28, 2021 | clinicaltrials |
| NCT03154710 | Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response | terminated | N/A | 52 | WepromOTHER | 1 | Apr 28, 2021 | clinicaltrials |
| NCT03968250 | CBT on Fatigue in Survivors of Hodgkin Lymphoma | completed | N/A | 17 | University of LeipzigOTHER | 1 | Apr 28, 2021 | clinicaltrials |
| NCT02301494 | Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma(CTCL) | withdrawn | N/A | 0 | Rochester General HospitalOTHER | 0 | Apr 27, 2021 | clinicaltrials |
| NCT00536601 | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors | completed | N/A | 174 | Roswell Park Cancer InstituteOTHER | 1 | Apr 22, 2021 | clinicaltrials |
| NCT02809222 | Plasmatic L-AScorbic Acid in MYelodyplastic Syndroms and Controls(PLASMYC) | completed | N/A | 138 | University Hospital, ToursOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT01685411 | Busulfan and Cyclophosphamide Followed By ALLO BMT | terminated | N/A | 5 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT00963911 | Validation of a Screening Tool in Geriatric Oncology(ONCODAGE) | completed | N/A | 1,674 | Institut BergoniéOTHER | 1 | Apr 5, 2021 | clinicaltrials |
| NCT00907452 | Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone | completed | N/A | 143 | Intergroupe Francophone du MyelomeNETWORK | 1 | Apr 1, 2021 | clinicaltrials |
| NCT02748850 | Evaluation of the Effectiveness of an Aldehyde Inhibitor Dehydrogenases (DIMATE) on the Cell Population Leukemic or Normal Stem(DIMATE) | unknown | N/A | 20 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04824950 | Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)(CAMIL) | recruiting | N/A | 87 | Centre Henri BecquerelOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT04822974 | TORQUETENOVIRUS IN CAR-T THERAPY: PREDICTION OF THE CRS(TTV-CART) | unknown | N/A | 20 | Institut Paoli-CalmettesOTHER | 0 | Mar 30, 2021 | clinicaltrials |
| NCT00861679 | Therapy Protocol Acute Lymphoblastic Leukemia Stem Cell Transplantation International(ALL SCT BFM) | completed | N/A | 552 | Hadassah Medical OrganizationOTHER | 1 | Mar 29, 2021 | clinicaltrials |
| NCT04319601 | Rituximab Combined With Chidamide and Lenalidomide for r/r AITL(AITL) | unknown | N/A | 26 | Zhejiang Cancer HospitalOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT01296178 | PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years | unknown | N/A | 200 | PETHEMA FoundationOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT01288222 | Selecting a Favorable KIR Donor in Unrelated HCT for AML | completed | N/A | 506 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Mar 11, 2021 | clinicaltrials |
| NCT04792593 | Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | unknown | N/A | 15 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Mar 11, 2021 | clinicaltrials |
| NCT03493906 | Patient Ambassador Support in Newly Diagnosed Patients With Acute Leukemia During Treatment(PAS) | completed | N/A | 61 | Rigshospitalet, DenmarkOTHER | 1 | Mar 10, 2021 | clinicaltrials |
| NCT04692948 | TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia | unknown | N/A | 5 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Mar 8, 2021 | clinicaltrials |
| NCT04785833 | CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia | unknown | N/A | 20 | PersonGen BioTherapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Mar 8, 2021 | clinicaltrials |
| NCT01807091 | Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome | completed | N/A | 17 | University of WashingtonOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT03562910 | Mobile-based Social Services Screening and Referral Tool in an Pediatric Emergency Department | completed | N/A | 266 | Boston Children's HospitalOTHER | 1 | Mar 2, 2021 | clinicaltrials |
| NCT04773769 | Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas | unknown | N/A | 54 | Auxilio Mutuo Cancer CenterOTHER | 1 | Feb 26, 2021 | clinicaltrials |
| NCT04758442 | Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology(Hemato-Vanco) | unknown | N/A | 40 | Ciusss de L'Est de l'Île de MontréalOTHER | 1 | Feb 17, 2021 | clinicaltrials |
| NCT04663516 | Effectiveness of Exercise Through Video Games in Reducing Fatigue Among Children With Leukemia | completed | N/A | 46 | King Saud UniversityOTHER | 1 | Feb 10, 2021 | clinicaltrials |
| NCT00943800 | Combined Haploidentical-Cord Blood Transplantation for Adults and Children | completed | N/A | 87 | University of ChicagoOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04723342 | Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot | unknown | N/A | 180 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT00176930 | Stem Cell Transplant for Hematological Malignancy | terminated | N/A | 330 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT00525057 | Dalteparin in Preventing DVT in Participants With Cancer | completed | N/A | 65 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 22, 2021 | clinicaltrials |
| NCT03955848 | INFUSION OF ALLOREACTIVE NATURAL KILLER (NK) CELLS AS CONSOLIDATION STRATEGY FOR ACUTE MYELOID LEUKEMIA PATIENTS(NKAML) | unknown | N/A | 80 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT03889483 | Neurophysiological Measurements Using the NeuroCatch™ Platform in Pediatric Concussion | unknown | N/A | 105 | Dr. Michael EsserOTHER | 1 | Jan 13, 2021 | clinicaltrials |
| NCT04701554 | EFFECT OF A 16-SESSION QIGONG PROGRAM ON PHYSICAL AND MENTAL HEALTH IN PATIENTS WITH LYMPHOMA: A RANDOMIZED CONTROLLED TRIAL | completed | N/A | 39 | Consuelo Lourdes Díaz RodríguezOTHER | 1 | Jan 8, 2021 | clinicaltrials |
| NCT04665063 | A Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Hodgkin's Lymphoma | unknown | N/A | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Dec 29, 2020 | clinicaltrials |
| NCT02710565 | Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma(EBUS) | completed | N/A | 22 | Mid and South Essex NHS Foundation TrustOTHER | 1 | Dec 23, 2020 | clinicaltrials |
| NCT02439112 | Exercise in Patients With Multiple Myeloma(EMMY) | completed | N/A | 102 | Zealand University HospitalOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT03804164 | Psycho-Educational Cognition Intervention in Patients With Blood and Lymph Cancer | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT04336501 | Efficacy and Safety Evaluation of IM19 CAR-T Cell Therapy for MRD+ After Transplantation | unknown | N/A | 20 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Dec 17, 2020 | clinicaltrials |
| NCT04666168 | A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma | unknown | N/A | 200 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Dec 14, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Jun 23, 2021source: clinicaltrials